ONGLYZA® (saxagliptin)

How do you choose the right DPP-4 inhibitor for your patients with type 2 diabetes?

Onglyza Therapeutic Indications

 

Onglyza is indicated in adults with type 2 diabetes mellitus to improve glycaemic control in combination with diet and exercise as:

(i)            monotherapy when metformin is inappropriate due to intolerance or contraindications;

(ii)           in combination with other medicinal products for the treatment of diabetes including insulin when these do not provide adequate glycaemic control.

1. ONGLYZA® Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/22315 (Last accessed August 2017).